散发性甲状腺髓样癌的多灶性:一项国际多中心研究
该国际多中心回顾性研究分析了11家机构29年间313例散发性甲状腺髓样癌(sMTC)患者,双侧病变占5.6%(17/306),多灶病变占16.0%(50/312)。同侧腺叶及峡部单灶时双侧病变为2.8%(6/212),多灶时为21.6%(8/37)(P<0.001)。作者认为5.6%的双侧病灶率支持全甲状腺切除仍为初始手术标准。
要点
- sMTC患者双侧病变率为5.6%(17/306),多灶病变率为16.0%(50/312)。
- 同侧腺叶及峡部单灶者双侧病变2.8%(6/212),多灶者21.6%(8/37),P<0.001。
- 作者认为5.6%的双侧病灶率支持全甲状腺切除仍为初始手术标准。
核心结论
- sMTC中5.6%的双侧病灶率提示全甲状腺切除应继续作为初始手术的标准治疗,因为不够完整的甲状腺手术可能无法完全处理原发灶。
- 当半甲状腺切除术后诊断为sMTC时,同侧肿瘤多灶性是否应作为决定是否需补行甲状腺全切的独立因素,尚待确定。
研究设计与样本
- 回顾性图表审查,纳入11家机构29年(1983-2011年)的sMTC患者。
- 共收集313例有记录的sMTC患者数据,来自四大洲七个国家。
主要发现
- 81.2%的患者RET胚系检测确认为阴性,其余18.8%家族史阴性且除MTC外无MEN2综合征表现。
- 双侧病变见于17/306(5.6%)患者,多灶病变见于50/312(16.0%)患者。
- 仅分析胚系阴性患者时,双侧病变率5.6%、多灶病变率17%,与总体相比无显著差异。
- 同侧腺叶及峡部单灶时双侧病变为6/212(2.8%),同侧腺叶或峡部多灶时双侧病变为8/37(21.6%)(P<0.001)。
- 未发现病灶多灶性存在地域差异。
临床怎么用
- 作者认为5.6%的双侧病灶率支持全甲状腺切除仍作为sMTC初始手术的标准治疗。
- 作者指出同侧肿瘤多灶性是否应作为半甲状腺切除后补行甲状腺全切的独立决定因素尚待确定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current surgical standard of care in sporadic medullary thyroid carcinoma (sMTC) consists of a minimum of total thyroidectomy with central neck dissection. Some have suggested thyroid lobectomy with isthmusectomy and central neck dissection for patients with sMTC, given their lower frequency of bilateral disease, although this topic has not been thoroughly studied. This study assessed the prevalence of multifocality in sMTC via a large international multi-institutional retrospective review to quantify this prevalence, including the impact of geography, to assess more accurately the risks associated with alternative surgical approaches. METHODS: A retrospective chart review of sMTC patients from 11 institutions over 29 years (1983-2011) was undertaken. Data regarding focality, extent of disease, RET germline analysis plus family and clinical history for multiple endocrine neoplasia type 2 (MEN2), and demographic data were collected and analyzed. RESULTS: Patients from four continents and seven countries were included in the sample. Data for 313 patients with documented sMTC were collected. Of these, 81.2% were confirmed with negative RET germline testing, while the remaining 18.8% demonstrated a negative family history and no manifestations of MEN2 syndromes other than MTC. Bilateral disease was identified in 17/306 (5.6%) patients, while multifocal disease was noted in 50/312 (16.0%) sMTC patients. When only accounting for germline negative patients, these rates were not significantly different (5.6% and 17%, respectively). Among them, when disease was unifocal in the ipsilateral lobe and isthmus, bilateral disease was present in 6/212 (2.8%) cases. When disease was multifocal in the ipsilateral lobe or isthmus, then bilateral disease was present in 8/37 (21.6%) cases (p < 0.001). No geographic differences in focality were identified. CONCLUSIONS: The 5.6% prevalence of bilateral foci in sMTC suggests that total thyroidectomy should remain the standard of care for initial surgery, as less complete thyroid surgery may fail to address fully the primary site of disease. Whether ipsilateral tumor focality should be an independent factor determining the need for completion thyroidectomy when sMTC is diagnosed after hemithyroidectomy remains to be determined.
引用
- Essig GF, Porter K, Schneider D, et al. Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study. Thyroid. 2016. PMID: 27604949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。